Literature DB >> 17244673

CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.

Yuwen Zhu1, Gefeng Zhu, Liqun Luo, Andrew S Flies, Lieping Chen.   

Abstract

CD137 has long been recognized as a costimulatory receptor for growth and functional maturation of recently activated T cells in the presence of T-cell receptor signal. In this report, we present the fact that, in the absence of MHC and antigen, triggering of CD137 by an agonist monoclonal antibody induces vigorous growth of both CD8(+) and CD4(+) T cells with memory phenotype, whereas it does not affect naive T cells. Moreover, T cells with memory phenotype accumulate progressively in transgenic mice overexpressing CD137 ligand. CD137-mediated proliferation of memory T cells is directly through CD137 on T cells and does not require IL-15 and IFN-gamma. Our results define a new role of CD137 signal in the growth of memory T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244673      PMCID: PMC1885532          DOI: 10.1182/blood-2006-10-043463

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Cutting edge: naive T cells masquerading as memory cells.

Authors:  K Murali-Krishna; R Ahmed
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

2.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

Authors:  Haidong Dong; Gefeng Zhu; Koji Tamada; Dallas B Flies; Jan M A van Deursen; Lieping Chen
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

3.  4-1BB-mediated immunotherapy of rheumatoid arthritis.

Authors:  Su K Seo; Jae H Choi; Young H Kim; Woo J Kang; Hye Y Park; Jae H Suh; Beom K Choi; Dass S Vinay; Byoung S Kwon
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

4.  Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.

Authors:  B R Blazar; B S Kwon; A Panoskaltsis-Mortari; K B Kwak; J J Peschon; P A Taylor
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.

Authors:  J L Cannons; Y Choi; T H Watts
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.

Authors:  Gayle Pulle; Mariana Vidric; Tania H Watts
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

7.  Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Authors:  A W Goldrath; L Y Bogatzki; M J Bevan
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

8.  Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells.

Authors:  B K Cho; V P Rao; Q Ge; H N Eisen; J Chen
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

9.  Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells.

Authors:  Ananda W Goldrath; Pallavur V Sivakumar; Moira Glaccum; Mary K Kennedy; Michael J Bevan; Christophe Benoist; Diane Mathis; Eric A Butz
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

10.  Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells.

Authors:  William C Kieper; Joyce T Tan; Brea Bondi-Boyd; Laurent Gapin; Jonathan Sprent; Rhodri Ceredig; Charles D Surh
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  31 in total

1.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancement.

Authors:  Kevin M Friedman; Laura E Devillier; Steven A Feldman; Steven A Rosenberg; Mark E Dudley
Journal:  J Immunother       Date:  2011 Nov-Dec       Impact factor: 4.456

3.  CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.

Authors:  Jun Wang; Wenxia Zhao; Liang Cheng; Mingzhou Guo; Dongling Li; Xiaozhu Li; Yi Tan; Suping Ma; Suyun Li; Yunsheng Yang; Lieping Chen; Shengdian Wang
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

Review 4.  Human cell-based artificial antigen-presenting cells for cancer immunotherapy.

Authors:  Marcus O Butler; Naoto Hirano
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 5.  SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.

Authors:  Rajesh K Sharma; Esma S Yolcu; Haval Shirwan
Journal:  Expert Rev Vaccines       Date:  2014-03       Impact factor: 5.217

6.  A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.

Authors:  Rich-Henry Schabowsky; Kutlu G Elpek; Shravan Madireddi; Rajesh K Sharma; Esma S Yolcu; Laura Bandura-Morgan; Robert Miller; Kathryn J MacLeod; Robert S Mittler; Haval Shirwan
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

7.  Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications.

Authors:  Shuhong Han; Yuju Huang; Yin Liang; Yuchin Ho; Yichen Wang; Lung-Ji Chang
Journal:  J Hematol Oncol       Date:  2009-08-06       Impact factor: 17.388

8.  Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.

Authors:  Gloria H Y Lin; Yuanqing Liu; Thanuja Ambagala; Byoung S Kwon; Pamela S Ohashi; Tania H Watts
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

Review 9.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

Review 10.  Advances in targeting cell surface signalling molecules for immune modulation.

Authors:  Sheng Yao; Yuwen Zhu; Lieping Chen
Journal:  Nat Rev Drug Discov       Date:  2013-02       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.